---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-24-000923"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:05:09.066208+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma sells 588,235 shares to director-owned entity for $200,000 at $0.34 each

## Summary
- Shares issued to Moran Global Strategies, owned by director James Moran, at $0.34/share.
- Total proceeds of $200,000; closing subject to NYSE American approval.
- Outstanding shares post-closing will be ~75,953,296; no warrants or options outstanding.
- Investor receives piggyback registration rights with expense cap of $2,500.
- Shares issued under Section 4(a)(2) exemption from registration.

## SEC filing metadata
- accession: 0001185185-24-000923
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000923/0001185185-24-000923-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000923/igc20240926_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-24-000923
- JSON: https://secwatch.observer/filing/0001185185-24-000923.json
- Plain text: https://secwatch.observer/filing/0001185185-24-000923.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.